"Designing Growth Strategies is in our DNA"

Enzyme Replacement Therapy Market Size, Share & Industry Analysis, By Drug Class (Alglucosidase alfa, Agalsidase, Pancrelipase, Idursulfase, Laronidase, Imiglucerase, Elosulfase alfa, Asfotasealfa, Galsulfase, Velaglucerase alfa, and Others), By Route of Administration (Parenteral and Oral), By Indication (Type 1 Gaucher Disease, Pompe Disease, MPS (Mucopolysaccharidosis), Exocrine Pancreatic Insufficiency (EPI), Fabry Disease, Hypophosphatasia, and Others), By End User (Hospitals and Homecare Settings & Infusion Centers), and Regional Forecast, 2024-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI106424

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Disorders, By Key Countries/Regions, 2023
    2. New Product Launches, By Key Players
    3. Key Industry Developments - Mergers, Acquisitions, etc.
    4. Impact of COVID-19 on the Enzyme Replacement Therapy Market
  5. Global Enzyme Replacement Therapy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Alglucosidase alfa
      2. Agalsidase
      3. Pancrelipase
      4. Idursulfase
      5. Laronidase
      6. Imiglucerase
      7. Elosulfase alfa
      8. Asfotase alfa
      9. Galsulfase
      10. Velaglucerase alfa
      11. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Indication
      1. Type 1 Gaucher disease
      2. Pompe Disease
      3. MPS (Mucopolysaccharidosis)
      4. Exocrine Pancreatic Insufficiency (EPI)
      5. Fabry Disease
      6. Hypophosphatasia
      7. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Homecare settings & Infusion Centers
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Enzyme Replacement Therapy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Alglucosidase alfa
      2. Agalsidase
      3. Pancrelipase
      4. Idursulfase
      5. Laronidase
      6. Imiglucerase
      7. Elosulfase alfa
      8. Asfotase alfa
      9. Galsulfase
      10. Velaglucerase alfa
      11. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Indication
      1. Type 1 Gaucher disease
      2. Pompe Disease
      3. MPS (Mucopolysaccharidosis)
      4. Exocrine Pancreatic Insufficiency (EPI)
      5. Fabry Disease
      6. Hypophosphatasia
      7. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Homecare settings & Infusion Centers
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Indication
      2. Canada
        1. By Indication
  7. Europe Enzyme Replacement Therapy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Alglucosidase alfa
      2. Agalsidase
      3. Pancrelipase
      4. Idursulfase
      5. Laronidase
      6. Imiglucerase
      7. Elosulfase alfa
      8. Asfotase alfa
      9. Galsulfase
      10. Velaglucerase alfa
      11. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Indication
      1. Type 1 Gaucher disease
      2. Pompe Disease
      3. MPS (Mucopolysaccharidosis)
      4. Exocrine Pancreatic Insufficiency (EPI)
      5. Fabry Disease
      6. Hypophosphatasia
      7. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Homecare settings & Infusion Centers
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K
        1. By Indication
      2. Germany
        1. By Indication
      3. France
        1. By Indication
      4. Italy
        1. By Indication
      5. Spain
        1. By Indication
      6. Scandinavia
        1. By Indication
      7. Rest of Europe
        1. By Indication
  8. Asia Pacific Enzyme Replacement Therapy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Alglucosidase alfa
      2. Agalsidase
      3. Pancrelipase
      4. Idursulfase
      5. Laronidase
      6. Imiglucerase
      7. Elosulfase alfa
      8. Asfotase alfa
      9. Galsulfase
      10. Velaglucerase alfa
      11. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Indication
      1. Type 1 Gaucher disease
      2. Pompe Disease
      3. MPS (Mucopolysaccharidosis)
      4. Exocrine Pancreatic Insufficiency (EPI)
      5. Fabry Disease
      6. Hypophosphatasia
      7. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Homecare settings & Infusion Centers
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
        1. By Indication
      2. China
        1. By Indication
      3. India
        1. By Indication
      4. Australia
        1. By Indication
      5. Southeast Asia
        1. By Indication
      6. Rest of Asia Pacific
        1. By Indication
  9. Latin America Enzyme Replacement Therapy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Alglucosidase alfa
      2. Agalsidase
      3. Pancrelipase
      4. Idursulfase
      5. Laronidase
      6. Imiglucerase
      7. Elosulfase alfa
      8. Asfotase alfa
      9. Galsulfase
      10. Velaglucerase alfa
      11. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Indication
      1. Type 1 Gaucher disease
      2. Pompe Disease
      3. MPS (Mucopolysaccharidosis)
      4. Exocrine Pancreatic Insufficiency (EPI)
      5. Fabry Disease
      6. Hypophosphatasia
      7. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Homecare settings & Infusion Centers
    5. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Brazil
        1. By Indication
      2. Mexico
        1. By Indication
      3. Rest of Latin America
        1. By Indication
  10. Middle East & Africa Enzyme Replacement Therapy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Alglucosidase alfa
      2. Agalsidase
      3. Pancrelipase
      4. Idursulfase
      5. Laronidase
      6. Imiglucerase
      7. Elosulfase alfa
      8. Asfotase alfa
      9. Galsulfase
      10. Velaglucerase alfa
      11. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Indication
      1. Type 1 Gaucher disease
      2. Pompe Disease
      3. MPS (Mucopolysaccharidosis)
      4. Exocrine Pancreatic Insufficiency (EPI)
      5. Fabry Disease
      6. Hypophosphatasia
      7. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Homecare settings & Infusion Centers
    5. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. GCC
        1. By Indication
      2. South Africa
        1. By Indication
      3. Rest of Middle East & Africa
        1. By Indication
  11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. BioMarin
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Leadiant Biosciences, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Pfizer Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Sanofi
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. AbbVie Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. JCR Pharmaceutical Co., Ltd.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Nestlé
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Enzyme Replacement Therapy Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 2: Global Enzyme Replacement Therapy Market Value Share (%), by Drug Class, 2023 & 2032

Figure 3: Global Enzyme Replacement Therapy Market Value Share (%), by Route of Administration, 2023 & 2032

Figure 4: Global Enzyme Replacement Therapy Market Value Share (%), by Indication, 2023 & 2032

Figure 5: Global Enzyme Replacement Therapy Market Value Share (%), by End User, 2023 & 2032

Figure 6: Global Enzyme Replacement Therapy Market Value (USD billion), by Region, 2023 & 2032

Figure 7: North America Enzyme Replacement Therapy Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 8: North America Enzyme Replacement Therapy Market Value Share (%), by Drug Class, 2023

Figure 9: North America Enzyme Replacement Therapy Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 10: North America Enzyme Replacement Therapy Market Value Share (%), by Route of Administration, 2023

Figure 11: North America Enzyme Replacement Therapy Market Value (USD billion), by Indication, 2023 & 2032

Figure 12: North America Enzyme Replacement Therapy Market Value Share (%), by Indication, 2023

Figure 13: North America Enzyme Replacement Therapy Market Value (USD billion), by End User, 2023 & 2032

Figure 14: North America Enzyme Replacement Therapy Market Value Share (%), by End User, 2023

Figure 15: North America Enzyme Replacement Therapy Market Value (USD billion), By Country, 2023 & 2032

Figure 16: North America Enzyme Replacement Therapy Market Value Share (%), By Country, 2023

Figure 17: Europe Enzyme Replacement Therapy Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 18: Europe Enzyme Replacement Therapy Market Value Share (%), by Drug Class, 2023

Figure 19: Europe Enzyme Replacement Therapy Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 20: Europe Enzyme Replacement Therapy Market Value Share (%), by Route of Administration, 2023

Figure 21: Europe Enzyme Replacement Therapy Market Value (USD billion), by Indication, 2023 & 2032

Figure 22: Europe Enzyme Replacement Therapy Market Value Share (%), by Indication, 2023

Figure 23: Europe Enzyme Replacement Therapy Market Value (USD billion), by End User, 2023 & 2032

Figure 24: Europe Enzyme Replacement Therapy Market Value Share (%), by End User, 2023

Figure 25: Europe Enzyme Replacement Therapy Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 26: Europe Enzyme Replacement Therapy Market Value Share (%), By Country/ Sub-region, 2023

Figure 27: Asia Pacific Enzyme Replacement Therapy Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 28: Asia Pacific Enzyme Replacement Therapy Market Value Share (%), by Drug Class, 2023

Figure 29: Asia Pacific Enzyme Replacement Therapy Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 30: Asia Pacific Enzyme Replacement Therapy Market Value Share (%), by Route of Administration, 2023

Figure 31: Asia Pacific Enzyme Replacement Therapy Market Value (USD billion), by Indication, 2023 & 2032

Figure 32: Asia Pacific Enzyme Replacement Therapy Market Value Share (%), by Indication, 2023

Figure 33: Asia Pacific Enzyme Replacement Therapy Market Value (USD billion), by End User, 2023 & 2032

Figure 34: Asia Pacific Enzyme Replacement Therapy Market Value Share (%), by End User, 2023

Figure 35: Asia Pacific Enzyme Replacement Therapy Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 36: Asia Pacific Enzyme Replacement Therapy Market Value Share (%), By Country/ Sub-region, 2023

Figure 37: Latin America Enzyme Replacement Therapy Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 38: Latin America Enzyme Replacement Therapy Market Value Share (%), by Drug Class, 2023

Figure 39: Latin America Enzyme Replacement Therapy Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 40: Latin America Enzyme Replacement Therapy Market Value Share (%), by Route of Administration, 2023

Figure 41: Latin America Enzyme Replacement Therapy Market Value (USD billion), by Indication, 2023 & 2032

Figure 42: Latin America Enzyme Replacement Therapy Market Value Share (%), by Indication, 2023

Figure 43: Latin America Enzyme Replacement Therapy Market Value (USD billion), by End User, 2023 & 2032

Figure 44: Latin America Enzyme Replacement Therapy Market Value Share (%), by End User, 2023

Figure 45: Latin America Enzyme Replacement Therapy Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 46: Latin America Enzyme Replacement Therapy Market Value Share (%), By Country/ Sub-region, 2023

Figure 47: Middle East & Africa Enzyme Replacement Therapy Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 48: Middle East & Africa Enzyme Replacement Therapy Market Value Share (%), by Drug Class, 2023

Figure 49: Middle East & Africa Enzyme Replacement Therapy Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 50: Middle East & Africa Enzyme Replacement Therapy Market Value Share (%), by Route of Administration, 2023

Figure 51: Middle East & Africa Enzyme Replacement Therapy Market Value (USD billion), by Indication, 2023 & 2032

Figure 52: Middle East & Africa Enzyme Replacement Therapy Market Value Share (%), by Indication, 2023

Figure 53: Middle East & Africa Enzyme Replacement Therapy Market Value (USD billion), by End User, 2023 & 2032

Figure 54: Middle East & Africa Enzyme Replacement Therapy Market Value Share (%), by End User, 2023

Figure 55: Middle East & Africa Enzyme Replacement Therapy Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 56: Middle East & Africa Enzyme Replacement Therapy Market Value Share (%), By Country/ Sub-region, 2023

Figure 57: Global Enzyme Replacement Therapy Market Share (%), By Company, 2023

Table 1: Global Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 2: Global Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 3: Global Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 4: Global Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 5: Global Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 6: North America Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 7: North America Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 8: North America Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 9: North America Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 10: North America Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 11: U.S. Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 12: Canada Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 13: Europe Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 14: Europe Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 15: Europe Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 16: Europe Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 17: Europe Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 18: Germany Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 19: U.K. Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 20: France Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 21: Italy Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 22: Spain Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 23: Scandinavia Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 24: Rest of Europe Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2033

Table 25: Asia Pacific Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 26: Asia Pacific Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 27: Asia Pacific Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 28: Asia Pacific Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 29: Asia Pacific Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 30: Japan Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 31: India Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 32: China Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 33: Australia Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 34: Southeast Asia Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 35: Rest of Asia Pacific Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 36: Latin America Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 37: Latin America Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 38: Latin America Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 39: Latin America Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 40: Latin America Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 41: Brazil Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 42: Mexico Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 43: Rest of Latin America Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 44: Middle East & Africa Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 45: Middle East & Africa Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 46: Middle East & Africa Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 47: Middle East & Africa Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 48: Middle East & Africa Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 49: GCC Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 50: South Africa Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 51: Rest of Middle East & Africa Enzyme Replacement Therapy Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Enzyme Replacement Therapy Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 150
Consulting Services
    How will you benefit from our consulting services ?